The Japanese unit of Swiss pharmaceutical giant Novartis has been ordered to temporarily suspend its operations for failing to report drug side effects, revealed the health ministry. This is reportedly a first for a pharmaceutical firm operating in Japan. During the 15-day suspension, which is to start from March 5, the company will not be able to sell most of its drugs. Drug-makers are required to report serious side effects of any drugs to the ministry within ...
via Medindia Health News
More READ
No comments:
Post a Comment